🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Severe Acute Respiratory Syndrome COronaVirus 2 (SARS-CoV2) is a new an...
Status
Completed
Location
Hospital de Urgência e Emergência de Rio Branco
Start Date
2020-03-28
Trial ID
NCT04321278
Treatments Being Tested
This is a Phase II interventional study will test the efficacy of quintuple...
Status
Completed
Location
ProgenaBiome
Start Date
2020-06-22
Trial ID
NCT04334512
Treatments Being Tested
The host response against the coronavirus 2 (SARS-CoV-2) appears to be medi...
Status
Suspended
Location
Hospital La Milagrosa, GenesisCare
Start Date
2020-04-21
Trial ID
NCT04394182
This study explores whether patients acutely hospitalized may have shorter ...
Status
Terminated
Location
Aalborg Sygehus
Start Date
2020-04-06
Trial ID
NCT04322396
Treatments Being Tested
A randomized, open-label, multicenter, three-arm clinical trial to study th...
Status
Unknown
Location
LifeFactors Zona Franca SAS
Start Date
2020-09
Trial ID
NCT04395170
Trial design: Prospective, multi-centre, randomised, pragmatic, double blin...
Status
Terminated
Location
František Duška
Start Date
2020-05-13
Trial ID
NCT04339816
Treatments Being Tested
The Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV2) has been id...
Status
Withdrawn
Location
Apsen Farmacêutica S.A.
Start Date
2020-04-30
Trial ID
NCT04361461
Treatments Being Tested
Currently there is no known effective therapy or vaccine for treatment of S...
Status
Completed
Location
Almaza Military Fever Hospital
Start Date
2020-04-15
Trial ID
NCT04530422
Treatments Being Tested
This study investigates the efficay and tolerance of 5-days course of hydro...
Status
Unknown
Location
University Hospital Farhat Hached
Start Date
2020-07
Trial ID
NCT04405921
Treatments Being Tested
The treatment of symptomatic, uncomplicated malaria caused by P. falciparum...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-03
Trial ID
NCT00282919
Treatments Being Tested